All Stories

  1. Hyaluronic acid–based systems for brain drug delivery: bridging material design and cellular response
  2. Evaluation of lemon-derived extracellular nanovesicles as a nanocarrier for Clemastine: insights from intracellular calcium dynamics in an oligodendrocyte cell model
  3. Intranasal Delivery of Dimethyl fumarate and Monomethyl fumarate Using Hyaluronic Acid-Based Hybrid Nanoparticles to Enhance CNS Bioavailability
  4. Nasal Emulgel’s Role in Preventing Coronavirus Infection
  5. Rose Bengal–Chitosan Nanocomposites for Oral Administration
  6. Silibinin-Loaded Amphiphilic PLGA–Poloxamer Nanoparticles: Physicochemical Characterization, Release Kinetics, and Bioactivity Evaluation in Lung Cancer Cells
  7. A thermosensitive chitosan hydrogel: An attempt for the nasal delivery of dimethyl fumarate
  8. Evaluating the efficacy of Rose Bengal-PVA combinations within PCL/PLA implants for sustained cancer treatment
  9. Plant-derived extracellular vesicles: a synergetic combination of a drug delivery system and a source of natural bioactive compounds
  10. Hyaluronic Acid-Based Nanoparticles Loaded with Rutin as Vasculo-Protective Tools against Anthracycline-Induced Endothelial Damages
  11. A water-soluble preparation for intravenous administration of isorhamnetin and its pharmacokinetics in rats
  12. Design and development of a chitosan-based nasal powder of dimethyl fumarate-cyclodextrin binary systems aimed at nose-to-brain administration. A stability study
  13. Improved pharmacokinetic and lymphatic uptake of Rose Bengal after transfersome intradermal deposition using hollow microneedles
  14. Corrigendum to “A technological comparison of freeze-dried poly-ɛ-caprolactone (PCL) and poly (lactic-co-glycolic acid) (PLGA) nanoparticles loaded with clozapine for nose-to-brain delivery” [J. Drug Deliv. Sci. Technol. 93 (March 2024), 105419]
  15. A technological comparison of freeze-dried poly-ɛ-caprolactone (PCL) and poly (lactic-co-glycolic acid) (PLGA) nanoparticles loaded with clozapine for nose-to-brain delivery
  16. Delivering hydrosoluble compounds through the skin: what are the chances?
  17. Green Routes for Bio-Fabrication in Biomedical and Pharmaceutical Applications
  18. Conjugation, Prodrug, and Co-Administration Strategies in Support of Nanotechnologies to Improve the Therapeutic Efficacy of Phytochemicals in the Central Nervous System
  19. Sericin/crocetin micro/nanoparticles for nucleus pulposus cells regeneration: An “active” drug delivery system
  20. Improving in vivo oral bioavailability of a poorly soluble drug: a case study on polymeric versus lipid nanoparticles
  21. Novel Utilization of Therapeutic Coatings Based on Infiltrated Encapsulated Rose Bengal Microspheres in Porous Titanium for Implant Applications
  22. Surfactant-Free Chitosan/Cellulose Acetate Phthalate Nanoparticles: An Attempt to Solve the Needs of Captopril Administration in Paediatrics
  23. Improving Dermal Delivery of Rose Bengal by Deformable Lipid Nanovesicles for Topical Treatment of Melanoma
  24. Electrochemotherapy of Deep-Seated Tumors: State of Art and Perspectives as Possible “EPR Effect Enhancer” to Improve Cancer Nanomedicine Efficacy
  25. Versatile Nasal Application of Cyclodextrins: Excipients and/or Actives?
  26. Crocetin as New Cross-Linker for Bioactive Sericin Nanoparticles
  27. Polymeric and Lipid Nanoparticles: Which Applications in Pediatrics?
  28. Nanotechnology-based rose Bengal: A broad-spectrum biomedical tool
  29. Transmucosal Solid Lipid Nanoparticles to Improve Genistein Absorption via Intestinal Lymphatic Transport
  30. Identifying a Role of Red and White Wine Extracts in Counteracting Skin Aging: Effects of Antioxidants on Fibroblast Behavior
  31. Polymeric nanomicelles based on inulin D α-tocopherol succinate for the treatment of diabetic retinopathy
  32. Nose-to-Brain Delivery of Antioxidants as a Potential Tool for the Therapy of Neurological Diseases
  33. Lipid-based nanocarriers for Rose Bengal dermal delivery: a promising approach in melanoma treatment
  34. Cellulose acetate phthalate-chitosan based nanoparticles for transdermal delivery of captopril in pediatric patients
  35. Solid Lipid Nanoparticles as Formulative Strategy to Increase Oral Permeation of a Molecule Active in Multidrug-Resistant Tuberculosis Management
  36. Investigation of Cytotoxicity and Cell Uptake of Cationic Beta-Cyclodextrins as Valid Tools in Nasal Delivery
  37. Investigation of Cytotoxicity and Cell Uptake of Cationic Beta-Cyclodextrins as Valid Tools in Nasal Delivery
  38. Bio-inspired apatite particles limit skin penetration of drugs for dermatology applications
  39. Chitosan Nanoparticles for Therapy and Theranostics of Hepatocellular Carcinoma (HCC) and Liver-Targeting
  40. <p>Clinical Assessment of New Topical Cream Containing Two Essential Oils Combined with Tretinoin in the Treatment of Acne</p>
  41. Colloidal Apatite Particles : A Multifunctional Platform in (Nano)Medicine
  42. Indocyanine Green Loaded Polymeric Nanoparticles: Physicochemical Characterization and Interaction Studies with Caco-2 Cell Line by Light and Transmission Electron Microscopy
  43. Antibacterial activity of Na-clinoptilolite against Helicobacter pylori: in-vitro tests, synergistic effect with amoxicillin and stability of the antibiotic formulated with the zeolite
  44. Harnessing Stem Cells and Neurotrophic Factors with Novel Technologies in the Treatment of Parkinson’s Disease
  45. Poly (ethyl 2-cyanoacrylate) nanoparticles (PECA-NPs) as possible agents in tumor treatment
  46. Nanoemulsions for “Nose-to-Brain” Drug Delivery
  47. Increasing protective activity of genistein by loading into transfersomes: A new potential adjuvant in the oxidative stress-related neurodegenerative diseases?
  48. Intranasal Delivery of Genistein-Loaded Nanoparticles as a Potential Preventive System against Neurodegenerative Disorders
  49. The Role of Combined Penetration Enhancers in Nasal Microspheres on In Vivo Drug Bioavailability
  50. Nanoparticles in detection and treatment of lymph node metastases: an update from the point of view of administration routes
  51. Biodegradable Microspheres as Intravitreal Delivery Systems for Prolonged Drug Release. What is their Eminence in the Nanoparticle Era?
  52. Hydroxypropyl-β-Cyclodextrin Formulated in Nasal Chitosan Microspheres as Candidate Therapeutic Agent in Alzheimer's Disease
  53. Aqueous injection of quercetin: An approach for confirmation of its direct in vivo cardiovascular effects
  54. Lymph node metastases: importance of detection and treatment strategies
  55. Prolonged skin retention of clobetasol propionate by bio-based microemulsions: a potential tool for scalp psoriasis treatment
  56. Engineered polymeric microspheres obtained by multi-step method as potential systems for transarterial embolization and intraoperative imaging of HCC: Preliminary evaluation
  57. Nose-to-brain delivery of BACE1 siRNA loaded in solid lipid nanoparticles for Alzheimer’s therapy
  58. In situ forming biodegradable poly(ε-caprolactone) microsphere systems: a challenge for transarterial embolization therapy. In vitro and preliminary ex vivo studies
  59. Natural collagenic skeleton of marine sponges in pharmaceutics: Innovative biomaterial for topical drug delivery
  60. Indocyanine green delivery systems for tumour detection and treatments
  61. Neuroprotective Effects of Engineered Polymeric Nasal Microspheres Containing Hydroxypropyl-β-cyclodextrin on β-Amyloid (1-42)–Induced Toxicity
  62. Bio-based topical system for enhanced salicylic acid delivery: preparation and performance of gels
  63. Particulate formulations based on chitosan for nose-to-brain delivery of drugs. A review
  64. Natural zeolites for pharmaceutical formulations: Preparation and evaluation of a clinoptilolite-based material
  65. Composite chitosan/alginate hydrogel for controlled release of deferoxamine: A system to potentially treat iron dysregulation diseases
  66. Propolis as lipid bioactive nano-carrier for topical nasal drug delivery
  67. Nasal chitosan microparticles target a zidovudine prodrug to brain HIV sanctuaries
  68. Engineered microparticles based on drug–polymer coprecipitates for ocular-controlled delivery of Ciprofloxacin: influence of technological parameters
  69. Synthesis of 2‐(Quinoxalin‐2‐ylamino‐benzotriazolyl) Pentanedioic Derivatives as Potential Anti‐Folate Agents
  70. From naturally-occurring neurotoxic agents to CNS shuttles for drug delivery
  71. Development of thermosensitive chitosan/glicerophospate injectablein situgelling solutions for potential application in intraoperative fluorescence imaging and local therapy of hepatocellular carcinoma: a preliminary study
  72. Solid microparticles based on chitosan or methyl-β-cyclodextrin: A first formulative approach to increase the nose-to-brain transport of deferoxamine mesylate
  73. The effect of formulative parameters on the size and physical stability of SLN based on “green” components
  74. Encapsulation and modified-release of thymol from oral microparticles as adjuvant or substitute to current medications
  75. Improvement of thymol properties by complexation with cyclodextrins: In vitro and in vivo studies
  76. Transarterial chemoembolization of hepatocellular carcinoma – agents and drugs: an overview. Part 2
  77. Transarterial chemoembolization of hepatocellular carcinoma. Agents and drugs: an overview. Part 1
  78. Influence of polymeric microcarriers on the in vivo intranasal uptake of an anti-migraine drug for brain targeting
  79. Evaluation of the effect of hydroxypropyl-β-cyclodextrin on topical administration of milk thistle extract
  80. Studies of Technological Parameters Influencing the Protein-Polymeric Nanoparticles Adsorption Process for Transmucosal Administration
  81. Mucoadhesive Drug Delivery Systems for Nose-to-Brain Targeting of Dopamine
  82. Solid lipid nanoparticles with and without hydroxypropyl-β-cyclodextrin: a comparative study of nanoparticles designed for colonic drug delivery
  83. Surface Thermodynamics of Mucoadhesive Dry Powder Formulation of Zolmitriptan
  84. Influence of Chitosan Glutamate on the in vivo Intranasal Absorption of Rokitamycin from Microspheres
  85. Development of solid nanoparticles based on hydroxypropyl-β-cyclodextrin aimed for the colonic transmucosal delivery of diclofenac sodium
  86. New chitosan derivatives for the preparation of rokitamycin loaded microspheres designed for ocular or nasal administration
  87. Evaluation of solid lipid microparticles produced by spray congealing for topical application of econazole nitrate
  88. Frontal polymerization as a new method for developing drug controlled release systems (DCRS) based on polyacrylamide
  89. Mucoadhesive microspheres for nasal administration of cyclodextrins
  90. Preparation, In Vitro Characterization and Preliminary In Vivo Evaluation of Buccal Polymeric Films Containing Chlorhexidine
  91. Improvement of Antiamoebic Activity of Rokitamycin Loaded in Chitosan Microspheres
  92. A New Sensitive Reversed‐phase High‐performance Liquid Chromatography Method for the Quantitative Determination of Metoclopramide in Canine Plasma
  93. Spray-dried microspheres based on methylpyrrolidinone chitosan as new carrier for nasal administration of metoclopramide
  94. Ketoprofen Spray-dried Microspheres Based on Eudragit® RS and RL: Study of the Manufacturing Parameters
  95. Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: in-vitro characterization, ex-vivo and in-vivo studies
  96. Nasal administration of Carbamazepine using chitosan microspheres: In vitro/in vivo studies
  97. Mucoadhesive microspheres for nasal administration of an antiemetic drug, metoclopramide: in-vitro/ex-vivo studies